logo
What's Up? Media Article on Menhaden Fails to Tell Both Sides

What's Up? Media Article on Menhaden Fails to Tell Both Sides

WASHINGTON, DC / ACCESS Newswire / May 16, 2025 / A recent article by Lisa Lewis in What's Up? Media ('The Osprey-Menhaden Bay Connection,' 5/16) presents a one-sided perspective that echoes the claims of a well-funded coalition of special interest environmental groups, while ignoring the extensive scientific evidence and stakeholder voices that contradict their narrative. The piece amplifies talking points that have been challenged by federal agencies, independent scientists, and frontline workers in the industry, while repeating several inaccurate claims about the menhaden fishery.
The Science Is Clear: Menhaden Are Not Overfished
The article asserts that industrial fishing is to blame for a decline in menhaden abundance in the Bay, while omitting the overwhelming scientific consensus to the contrary. The Atlantic States Marine Fisheries Commission (ASMFC), the agency that manages menhaden for East Coast states, has repeatedly found the stock to be healthy and sustainably managed. According to the Commission's most recent stock assessment, released in 2022, menhaden are not overfished, and overfishing is not occurring.
The fishery operates under Ecological Reference Points, an ecosystem-based management approach that accounts for the needs of predators like striped bass, bluefish, and weakfish. In fact, less than 0.5% of menhaden born each year are harvested. The menhaden fishery is also certified sustainable by the Marine Stewardship Council (MSC), the gold standard for international third-party environmental certification.
USGS and VIMS Question Osprey Diet Claims
The article relies on preliminary findings from a 2024 survey by the Center for Conservation Biology, suggesting menhaden scarcity is causing osprey chick reproduction failure in parts of the Chesapeake Bay. However, it does not mention a recent U.S. Geological Survey (USGS) letter to the House Natural Resources Committee, which responded to congressional questions about the osprey claims.
In its letter, the USGS found no biologically significant change in the proportion of menhaden in osprey diets from 2006 to 2021. Menhaden made up a slightly higher portion of the diet in 2021, and any apparent changes were not statistically significant. The letter explained that many other factors - including adverse weather, nesting density, predator interactions, and prey accessibility - can impact osprey chick survival. It emphasized that striped bass is a key prey species for ospreys in parts of the Bay; striped bass is currently overfished, primarily due to recreational fishing mortality.
Scientists with the Virginia Institute of Marine Science (VIMS) also questioned the purported menhaden-osprey connection in a 2024 peer-reviewed response. VIMS noted that a previous 2023 study on osprey did not establish a causal relationship between menhaden availability and osprey reproduction.
Ocean Harvesters Is a U.S. Company with American Crews
The article claims the fishery is dominated by a 'Canadian-owned company,' which is wrong. While Omega Protein is part of the international Cooke, Inc. family of companies, the vessels that harvest menhaden are owned and operated by Ocean Harvesters - a U.S.-based, independently owned company with American-flagged vessels and unionized American crews. In 2024, the U.S. Maritime Administration confirmed the company is in full compliance with the American Fisheries Act, which regulates participation by foreign companies in U.S. fisheries.
Omega Protein, based in Reedville, Virginia, processes the fish caught by Ocean Harvesters under a service agreement between the companies. These jobs support rural communities and represent one of the largest unionized workforces in the region.
On Transparency and Collaboration
The article repeats the false claim that Omega Protein refuses to share data with scientists, citing concerns raised by the Chesapeake Bay Foundation's Dr. Allison Colden. This suggestion is simply not true. Confidential landings data from the menhaden reduction fishery is routinely provided to NOAA, the ASMFC, and state regulators-including the Virginia Marine Resources Commission. This data is not casually handed out to competitors or to researchers affiliated with advocacy groups seeking to undermine the fishery; rather, it is shared with official scientific and regulatory bodies responsible for stock assessments and management decisions.
This data is not publicly distributed because it is protected under federal confidentiality laws, just like commercial data from all fisheries. However, it is actively used in the development of all stock assessments, including the Ecological Reference Points that Dr. Colden herself has publicly supported. The entire scientific understanding of the health of the menhaden stock depends on this data. To suggest otherwise is either a misunderstanding of fisheries science or a willful attempt to mislead the public.
In fact, the fishery has supported and participated in more than 15 research projects in collaboration with institutions such as VIMS and NOAA and contributed to the design of the Bay-specific study referenced in the article. Industry critics can't have it both ways-celebrating models built on this data while claiming the data isn't provided.
Reasonable Precautions Are Already in Place
The article accurately notes the Chesapeake Bay harvest cap has been cut repeatedly, from 109,020 metric tons in 2006 to 51,000 metric tons today - a reduction of more than 50%. That cap remains in place today as a precautionary safeguard, not in response to any scientifically derived or observed population decrease necessitating harvest cuts.
Local Economic and Social Contributions
In addition to its ecological and regulatory strengths, the menhaden fishery is a major driver of the local economy in Northumberland County, Virginia. The fishery, primarily operated by Omega Protein and its harvesting partner Ocean Harvesters, generates over $100 million in annual economic activity. If operations ceased, the region would face the loss of over 500 direct and indirect jobs, with Northumberland County bearing the brunt of this impact.
The industry directly employs over 260 individuals and provides an annual payroll and benefits package of approximately $23 million. Fishery workers are represented by the United Food and Commercial Workers Union (UFCW) Local 400, which ensures strong collective bargaining rights, fair wages, and safe working conditions. This makes the menhaden fishery one of the largest union-represented private-sector employers in the region.
Importantly, the fishery is one of Northumberland County's largest minority employers, providing stable, long-term jobs to a historically underrepresented workforce. The industry's community impact extends to local vendors and businesses supported by its operations.
A Note on Media Integrity
It's worth noting that Lisa Lewis's article ends with a telling admission: 'Special thanks to Valerie Keefer, Maryland communications & media relations manager, CBF, and Kenny Fletcher, director of communications and media relations, CBF.' This acknowledgment makes clear that the story was heavily influenced-if not directly shaped-by the Chesapeake Bay Foundation's communications team. It raises serious questions about the objectivity of the piece, which lacks input from fisheries scientists, union workers, and others with direct knowledge of the fishery. For readers seeking a balanced view of the Chesapeake Bay's most regulated and scrutinized fishery, this article falls short.
One modest but important positive is that Dr. Bryan Watts, quoted throughout the article, acknowledges uncertainty about the cause of reproductive issues in ospreys. This marks a notable shift from his previous public statements, which more definitively attributed the issue to the menhaden fishery. Dr. Watts now says, 'We do not know why menhaden have become less available to ospreys,' reflecting a more nuanced and scientifically appropriate stance given the complex web of factors at play.
The menhaden fishery is highly regulated, science-based, and a vital part of the Bay's economy. The complex ecology of ospreys, striped bass, and menhaden deserves continued research - and that research should be conducted in good faith, not through premature conclusions or special interest narratives.
About the Menhaden Fisheries Coalition
The Menhaden Fisheries Coalition (MFC) is a collective of menhaden fishermen, related businesses, and supporting industries. Comprised of businesses along the Atlantic and Gulf coasts, the Menhaden Fisheries Coalition conducts media and public outreach on behalf of the menhaden industry to ensure that members of the public, media, and government are informed of important issues, events, and facts about the fishery.
Media Contact:
Menhaden Fisheries Coalition
(202) 595-1212
www.menhaden.org
SOURCE: Menhaden Fisheries Coalition
press release

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Patients With HS, Obesity Report Improvements With GLP-1 RAs
Patients With HS, Obesity Report Improvements With GLP-1 RAs

Medscape

timean hour ago

  • Medscape

Patients With HS, Obesity Report Improvements With GLP-1 RAs

In a survey of 22 patients with hidradenitis suppurativa (HS), more than two thirds reported symptom improvement after treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs). METHODOLOGY: Researchers conducted a cross-sectional survey of 22 adults (average age, 45 years; 90.9% women) with HS who were treated with GLP-1 RAs at the University of Pennsylvania's Dermatology Department between January 2019 and August 2024. Most participants were non-Hispanic (90.9%), 54.5% were Black, and 36.4% were White; 89.5% were classified as overweight or having obesity. GLP-1 RAs prescriptions were semaglutide (40.9%), tirzepatide (36.4%), dulaglutide (18.2%), or liraglutide (4.5%), with an average treatment duration of 17 months (range, 2-108 months). Primary outcomes were HS severity and quality of life. TAKEAWAY: Most participants (77.3%) achieved weight loss averaging 31 lb; 68.2% reported improvement in HS-specific health, while 31.8% reported no change in their condition. Patient-reported symptom improvements included reduced flares (61.9%), new lesions (66.7%), pain (52.4%), drainage (61.9%), itch (47.6%), and odor (42.9%). Common side effects included gastrointestinal symptoms, allergic reactions, headaches, menstrual spotting, and appetite suppression. Nearly 60% of patients reported that HS had less impact on their daily activities, with the same percentage stating they would recommend GLP-1 RAs to other patients. IN PRACTICE: 'These data suggest GLP-1 RAs may play an important adjunctive role in the treatment of HS, particularly given the high prevalence of obesity and diabetes in the HS population,' the study authors wrote. 'Randomized controlled studies with robust patient and dermatologist-reported endpoints,' they added, 'are needed to confirm these findings and establish clinical guidelines for use of GLP-1 RAs' in HS. SOURCE: The study was led by Radhika Gupta, BA, University of Pennsylvania, Philadelphia. It was published online on May 29 in JAAD International . LIMITATIONS: Study limitations included small size, lack of clinician assessment, high nonresponse rate, and potential recall bias. DISCLOSURES: The study received funding through a philanthropic gift for HS research. Gupta disclosed being a consultant for Cabaletta Bio. One author reported receiving research funding from Amgen, Boehringer Ingelheim, Cabaletta Bio, and InflaRx. Another author reported being a consultant for Sonoma Biotherapeutics, and the fourth author reported being a consultant for Vertex Pharmaceuticals.

Sacramento to release 400,000 sterile mosquitoes to fight off invasive ones
Sacramento to release 400,000 sterile mosquitoes to fight off invasive ones

CBS News

time2 hours ago

  • CBS News

Sacramento to release 400,000 sterile mosquitoes to fight off invasive ones

Sacramento aims to fight off invasive mosquitoes by releasing thousands more Sacramento aims to fight off invasive mosquitoes by releasing thousands more Sacramento aims to fight off invasive mosquitoes by releasing thousands more SACRAMENTO — Sacramento is launching a new tactic to stop the spread of invasive mosquitoes that can infect people with Zika and dengue fever. The plan, which was just approved by the Environmental Protection Agency, is to release 400,000 live mosquitoes into the environment. "We need ways to combat these mosquitoes, which are posing a public health threat," said Luz Maria Robles with the Sacramento Yolo Mosquito and Vector Control District. The swarm will initially be released across 100 acres of Sacramento's south Natomas neighborhood, which has been the biggest breeding ground. To ensure the mosquitoes are safe for the public, only sterile males will be used in the program. "Male mosquitoes do not bite, so while you might see more mosquitoes than usual, we want those males to mate with the wild females because once they do, their eggs will not hatch," Robles said. Fresno's consolidated mosquito district was the first in California to use this technique, and they say data shows it is safe and effective. "We had tremendous success with that program in the areas where we did release," said Jodi Holeman, manager of the Fresno abatement district. "We got in excess of 98% suppression." If successful in south Natomas, releases could occur in other Sacramento neighborhoods, Robles said. The Sacramento Yolo Mosquito and Vector Control District says it will cost about $33,000 to purchase the mosquitoesnd the releases are scheduled to begin on july 8th.

Watch this SpaceX rocket launch on 15th anniversary of first Falcon 9 liftoff
Watch this SpaceX rocket launch on 15th anniversary of first Falcon 9 liftoff

Digital Trends

time5 hours ago

  • Digital Trends

Watch this SpaceX rocket launch on 15th anniversary of first Falcon 9 liftoff

A SpaceX Falcon 9 rocket roared skyward on Wednesday on what was also the 15th anniversary of the first-ever Falcon 9 launch. The anniversary mission launched from the Vandenberg Space Force Base in California, deploying 27 Starlink internet satellites to low-Earth orbit. Here's the SpaceX rocket leaving the launchpad: Falcon 9 lifts off from pad 4E in California on the 15th anniversary of its first launch — SpaceX (@SpaceX) June 4, 2025 Wednesday's mission was the 26th flight for this particular first-stage booster, which previously launched Sentinel-6 Michael Freilich, DART, Transporter-7, Iridium OneWeb, SDA-0B, NROL-113, NROL-167, NROL-149, and 17 Starlink missions. Recommended Videos Following stage separation, the Falcon 9 booster returned and landed on the Of Course I Still Love You droneship, which was waiting in the Pacific Ocean. It's been a busy 15 years for SpaceX, during which it has perfected the launch-to-landing system of its workhorse Falcon 9 rocket. SpaceX's first launch of the Falcon 9 took at Cape Canaveral in Florida on June 4, 2010. The inaugural flight marked a significant milestone in commercial spaceflight history as it was the first time that a privately developed rocket of Falcon 9's size had been successfully launched to orbit. The mission deployed a prototype of the Dragon spacecraft, called the Dragon Spacecraft Qualification Unit. The uncrewed test flight evaluated the rocket's performance and the spacecraft's aerodynamic capabilities, with the latter completing more than 300 orbits before reentering Earth's atmosphere and burning up later that month. You can watch the highlights of the historic flight below: The successful inaugural launch laid the foundation for SpaceX's subsequent achievements, including the first commercial spacecraft to dock with the International Space Station (ISS) in 2012 and the development of reusable rocket technology. Today, the Falcon 9, Dragon, and Crew Dragon make regular runs to the ISS, carrying both cargo and crew. The workhorse rocket also deploys satellites for government and commercial entities globally, and, as in Wednesday's mission, is helping to build out SpaceX's internet-from-space Starlink service with numerous satellite deployments in low-Earth orbit. Importantly, the Falcon 9 was also a stepping stone to the development of the mighty Starship, the most powerful rocket ever to fly. The Starship comprises the first-stage Super Heavy booster and the upper-stage Starship spacecraft. The 120-meter-tall vehicle made its first flight in April 2023, and its most recent one just last month. The rocket will one day be used for crew and cargo voyages to the moon, and possibly Mars, too.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store